Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s.
暂无分享,去创建一个
Y. Shibamoto | M. Hasegawa | T. Fujii | M. Kenjo | H. Ogino | N. Hayabuchi | M. Nishio | S. Ishihara | M. Sougawa | Kazunori Suzuki | E. Kato | T. Kawamura
[1] K. Takakura,et al. Primary central nervous system lymphoma in Japan , 1994, Journal of Neuro-Oncology.
[2] Q. Le,et al. Extranodal nonorbital indolent lymphomas of the head and neck: relationship between tumor control and radiotherapy. , 2004, International journal of radiation oncology, biology, physics.
[3] A. López-Guillermo,et al. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. , 2004, International journal of radiation oncology, biology, physics.
[4] Y. Shibamoto,et al. Primary central nervous system lymphoma in Japan 1995–1999: changes from the preceding 10 years , 2004, Journal of Cancer Research and Clinical Oncology.
[5] S. Aebi,et al. Combination Chemotherapy with High-dose Methotrexate and Cytarabine with or without Brain Irradiation for Primary Central Nervous System Lymphomas , 2002, Journal of Neuro-Oncology.
[6] Y. Shibamoto,et al. Systemic Chemotherapy with Vincristine, Cyclophosphamide, Doxorubicin and Prednisolone Following Radiotherapy for Primary Central Nervous System Lymphoma: A Phase II Study , 1999, Journal of Neuro-Oncology.
[7] N. Arita. Therapeutic Management of Primary Central Nervous System Lymphoma , 2004 .
[8] M. van Glabbeke,et al. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] L. Deangelis. Primary central nervous system lymphoma: a curable brain tumor. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Y. Tamaki,et al. Comparable outcomes of radiation therapy without high-dose methotrexate for patients with primary central nervous system lymphoma. , 2003, Japanese journal of clinical oncology.
[11] S. Marnitz,et al. Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy. , 2003, International journal of radiation oncology, biology, physics.
[12] J. Blay,et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Y. Shibamoto,et al. Stage I and II aggressive B-cell lymphomas of the head and neck: radiotherapy alone as a treatment option and the usefulness of the new prognostic index B-ALPS. , 2003, International journal of radiation oncology, biology, physics.
[14] Y. Shibamoto,et al. Is whole‐brain irradiation necessary for primary central nervous system lymphoma? , 2003, Cancer.
[15] L. Deangelis,et al. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Raemaekers,et al. Dose MTX-based chemotherapy followed by consolidating radiotherapy in Non-Aids related Primary Central Nervous System Lymphoma. , 2002 .
[17] J. Blay,et al. Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate. , 2001, International journal of radiation oncology, biology, physics.
[18] Y. Shibamoto,et al. Intracranial germinoma: radiation therapy with tumor volume-based dose selection. , 2001, Radiology.
[19] L. Deangelis,et al. Treatment for primary CNS lymphoma: the next step. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] P. Lantos,et al. A medical research council randomized trial in patients with primary cerebral non‐Hodgkin lymphoma , 2000, Cancer.
[21] M. Reni,et al. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] J. Blay,et al. The clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphoma (PCNSL) treated with upfront high-dose methotrexate (≥1 g/m2 HD-MTX) , 2000 .
[23] Y. Shibamoto,et al. Primary central nervous system lymphoma in Japan: a nationwide survey. , 1999, International journal of radiation oncology, biology, physics.
[24] J. O'fallon,et al. Primary central nervous system non-Hodgkin's lymphoma (PCNSL): survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) Study 86-72-52. , 1999, International journal of radiation oncology, biology, physics.
[25] J. Corry,et al. Primary central nervous system lymphoma: age and performance status are more important than treatment modality. , 1998, International journal of radiation oncology, biology, physics.
[26] S. Ashley,et al. Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL). , 1998, International journal of radiation oncology, biology, physics.
[27] J. Blay,et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] K. Sartor,et al. Primäre maligne Lymphome des Gehirns , 1997, Der Radiologe.
[29] R. Abrams,et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] F. Hochberg,et al. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. , 1994, Journal of neurosurgery.
[31] D. Nelson,et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. , 1992, International journal of radiation oncology, biology, physics.
[32] H. Hirschberg,et al. Primary Malignant Lymphoma of the Brain: A report of 24 cases from the Norwegian Radium Hospital , 1992 .
[33] Y. Shibamoto,et al. Improved survival rate in primary intracranial lymphoma treated by high‐dose radiation and systemic vincristine‐doxorubicin‐cyclophosphamide‐prednisolone chemotherapy , 1990, Cancer.
[34] Douglas C. Miller,et al. Primary central nervous system lymphoma. , 1988, Journal of neurosurgery.
[35] S. Leibel,et al. Radiation therapy for neoplasms of the brain. , 1987, Journal of neurosurgery.
[36] W. Ballinger,et al. Primary central nervous system non-Hodgkin's lymphoma , 1981 .
[37] P. Littman,et al. Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases , 1975, Cancer.